Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ChemoCentryx Inc (NASDAQ:CCXI)

7.32
Delayed Data
As of Sep 18
 +0.11 / +1.53%
Today’s Change
4.62
Today|||52-Week Range
10.80
-1.08%
Year-to-Date
No recent news for ChemoCentryx Inc.

Today’s Trading

Previous close7.21
Today’s open7.25
Day’s range7.22 - 7.44
Volume158,401
Average volume (3 months)172,518
Market cap$356.5M
Dividend yield--
Data as of 09/18/2017

Growth & Valuation

Earnings growth (last year)+20.37%
Earnings growth (this year)-4.26%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales28.79
Price/Book7.05

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...+0.35+2.32%
TTPHTetraphase Pharmaceu...+0.17+2.45%
CNCEConcert Pharmaceutic...+0.30+2.06%
AQXPAquinox Pharmaceutic...+0.98+7.63%
Data as of 09/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$11.9M
Annual profit (last year)-$40.0M
Net profit margin-334.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Thomas J. Schall
CFO, Secretary, CAO &
Principal Accounting Officer
Susan M. Kanaya
Corporate headquarters
Mountain View, California

Forecasts